- Email: [email protected]
University of Leeds research centre to develop advanced chemical products
F O C U S significant contributor to the global sales growth. Original Source: Novozymes, website: http://www.novozymes.com (24 Apr 2014) © Novozymes 2014
Colgate announces 1Q 2014 results Colgate-Palmolive Co reported worldwide net sales of $4325 M in 1Q 2014, even with 1Q 2013. Global unit volume grew 5.0%, pricing increased 1.5% and foreign exchange was negative 6.5%. Organic sales grew 6.5% helped in particular by doubledigit growth in emerging countries. Net income was $388 M, down from $460 M in 1Q 2013, due to restructuring costs and the strong fall in value of the Venezuelan currency (Bolivar). Gross profit margin was 58.4% versus 58.3% in 1Q 2013. Operating profit decreased 15% to $634 M compared to $742 M in 1Q 2013. In North America, ColgatePalmolive’s reported net sales increased 2.5% in 1Q 2014. Unit volume increased 4.5% with 1.0% lower pricing and 1.0% negative foreign exchange. Organic sales also increased by 3.5%. Operating profit was $216 M in 1Q 2014, even with 1Q 2013. Net sales in Latin America decreased 5.0% in 1Q 2014. Unit volume increased 4.5% with 6.5% higher pricing and 16.0% negative foreign exchange. Volume gains were led by Venezuela, Brazil, Mexico and Colombia. Organic sales for Latin America increased 11.0%. Operating profit decreased 7% to $290 M, due in part to the Venezuelan currency situation. Colgate’s reported net sales in Europe/South Pacific increased 2.0% in 1Q 2014. Unit volume increased 3.5% with 2.5% lower pricing and 1.0% positive foreign exchange. Volume gains were led by Australia, Poland, France and the UK. Organic sales for Europe/South Pacific increased 1.5%. Operating profit increased 9% to $217 M, primarily due to an increase in gross profit as a result of cost savings. In Asia, reported net sales increased 2.5% during 1Q 2014. Unit volume increased 7.0%, with 0.5% higher pricing and 5.0% negative foreign exchange. Volume gains were led by the Greater China region, India, the Philippines and Malaysia. Organic sales for Asia increased 7.5%. Operating profit increased 4% to $193 JULY 2014
O N
S U R FA C TA N T S
M boosted by cost savings and pricing. The company’s reported net sales in Africa/Eurasia decreased 0.5% during 1Q 2014. Unit volume increased 9.5% with 0.5% higher pricing and 10.5% negative foreign exchange. Volume gains were led by Turkey, Russia, the Central Asia/Caucasus region and South Africa. Organic sales for Africa/Eurasia increased 10.0%. Operating profit in the region decreased 5% to $59 M, affected by higher raw and packaging material costs. Original Source: Colgate, website: http://www.colgate.co.uk/ (25 Apr 2014) © Colgate Palmolive 2014. Original Source: Handelsblatt Wirtschafts- und Finanzzeitung, 25 Apr 2014, (Website: http://www.handelsblatt.com) (in German) © Verlagsgruppe Handelsblatt GmbH & Co KG 2014
and industrial product ingredients from biomass via its proprietary hybrid ozonolysis process, has begun manufacturing product ingredients using a pilot reactor and is in discussions with several prospective customers and partners in the fragrances and flavours, and cosmetics industries. In addition to new proprietary ingredients, P2’s products will include vegetable-based equivalents of chemical ingredients previously only available from petrochemical sources and will be suitable for direct substitution for such ingredients in customer products. Original Source: Connecticut Innovations, 2014. Found on SpecialChem Cosmetics and Personal Care Innovation and Solutions, 7 Apr 2014, (Website: http://www.specialchem4cosmetics.com)
Procter & Gamble’s profits more than expected
University of Leeds research centre to develop advanced chemical products
Procter & Gamble (P&G) had profits up in its 3Q (period ended 31 Mar 2014) thanks to savings and a focus on expensive branded products. Net profits were up year on year from $2.57 bn to $2.61 bn, though net sales were flat at $20.56 bn. The company sees itself on course for achieving its full-year targets. It is looking to increase sales by 3-4% (organically), and earnings per share by 5-7%.
A total of 50 new research students will be funded by the University of Leeds’ £7 M Centre for Doctoral Training (CDT) in Complex Particulate Products and Processes. The first batch of 10 doctorate students are set to start in Oct 2014. Half of the funding will be covered by the UK government, with the remainder supported by academic and industrial partners such as Procter & Gamble, Syngenta, Infineum, Glaxo-SmithKline, Pfizer and AstraZeneca. Research will focus on microencapsulation, which would enable controlled release and preservation of active ingredients such as pesticides and cleaning products.
Original Source: Chemie Aktuell, 23 Apr 2014, (Website: http://www.maerkte-weltweit.de) (in German) © MBM Martin Brueckner Medien GmbH 2014
COMPANY NEWS CI invests in P2 Science Connecticut Innovations (CI) has made a $500,000 investment in P2 Science Inc of New Haven, CT, USA, through its Eli Whitney Equity Fund. This investment was part of a $1 M Series A funding round also involving Elm Street Ventures. In 2013, CI provided P2 Science with a $500,000 seed investment [Focus on Surfactants, Sep 2013] and earlier provided pre-seed funding. P2 Science, a speciality chemical company dedicated to producing high-value, high-margin consumer
Original Source: Chemical Weekly, 8 Apr 2014, 173 (Website: http://www.chemicalweekly.com) © Sevak Publications & Chemical Weekly Database P Ltd 2014
Dolomite, Sphere Fluidics partner to deliver world-leading droplet-based technology Sphere Fluidics and The Dolomite Centre Ltd have signed an exclusive distributor agreement for Sphere Fluidics’ trademarked range of unique biochips, surfactants and other specialist chemicals for picodroplet applications. These will be promoted and sold via Dolomite’s worldwide sales channels. Original Source: BioSpace, 1 May 2014, (Website: http://www.biospace.com)
7
Colgate announces 1Q 2014 results Colgate-Palmolive Co reported worldwide net sales of $4325 M in 1Q 2014, even with 1Q 2013. Global unit volume grew 5.0%, pricing increased 1.5% and foreign exchange was negative 6.5%. Organic sales grew 6.5% helped in particular by doubledigit growth in emerging countries. Net income was $388 M, down from $460 M in 1Q 2013, due to restructuring costs and the strong fall in value of the Venezuelan currency (Bolivar). Gross profit margin was 58.4% versus 58.3% in 1Q 2013. Operating profit decreased 15% to $634 M compared to $742 M in 1Q 2013. In North America, ColgatePalmolive’s reported net sales increased 2.5% in 1Q 2014. Unit volume increased 4.5% with 1.0% lower pricing and 1.0% negative foreign exchange. Organic sales also increased by 3.5%. Operating profit was $216 M in 1Q 2014, even with 1Q 2013. Net sales in Latin America decreased 5.0% in 1Q 2014. Unit volume increased 4.5% with 6.5% higher pricing and 16.0% negative foreign exchange. Volume gains were led by Venezuela, Brazil, Mexico and Colombia. Organic sales for Latin America increased 11.0%. Operating profit decreased 7% to $290 M, due in part to the Venezuelan currency situation. Colgate’s reported net sales in Europe/South Pacific increased 2.0% in 1Q 2014. Unit volume increased 3.5% with 2.5% lower pricing and 1.0% positive foreign exchange. Volume gains were led by Australia, Poland, France and the UK. Organic sales for Europe/South Pacific increased 1.5%. Operating profit increased 9% to $217 M, primarily due to an increase in gross profit as a result of cost savings. In Asia, reported net sales increased 2.5% during 1Q 2014. Unit volume increased 7.0%, with 0.5% higher pricing and 5.0% negative foreign exchange. Volume gains were led by the Greater China region, India, the Philippines and Malaysia. Organic sales for Asia increased 7.5%. Operating profit increased 4% to $193 JULY 2014
O N
S U R FA C TA N T S
M boosted by cost savings and pricing. The company’s reported net sales in Africa/Eurasia decreased 0.5% during 1Q 2014. Unit volume increased 9.5% with 0.5% higher pricing and 10.5% negative foreign exchange. Volume gains were led by Turkey, Russia, the Central Asia/Caucasus region and South Africa. Organic sales for Africa/Eurasia increased 10.0%. Operating profit in the region decreased 5% to $59 M, affected by higher raw and packaging material costs. Original Source: Colgate, website: http://www.colgate.co.uk/ (25 Apr 2014) © Colgate Palmolive 2014. Original Source: Handelsblatt Wirtschafts- und Finanzzeitung, 25 Apr 2014, (Website: http://www.handelsblatt.com) (in German) © Verlagsgruppe Handelsblatt GmbH & Co KG 2014
and industrial product ingredients from biomass via its proprietary hybrid ozonolysis process, has begun manufacturing product ingredients using a pilot reactor and is in discussions with several prospective customers and partners in the fragrances and flavours, and cosmetics industries. In addition to new proprietary ingredients, P2’s products will include vegetable-based equivalents of chemical ingredients previously only available from petrochemical sources and will be suitable for direct substitution for such ingredients in customer products. Original Source: Connecticut Innovations, 2014. Found on SpecialChem Cosmetics and Personal Care Innovation and Solutions, 7 Apr 2014, (Website: http://www.specialchem4cosmetics.com)
Procter & Gamble’s profits more than expected
University of Leeds research centre to develop advanced chemical products
Procter & Gamble (P&G) had profits up in its 3Q (period ended 31 Mar 2014) thanks to savings and a focus on expensive branded products. Net profits were up year on year from $2.57 bn to $2.61 bn, though net sales were flat at $20.56 bn. The company sees itself on course for achieving its full-year targets. It is looking to increase sales by 3-4% (organically), and earnings per share by 5-7%.
A total of 50 new research students will be funded by the University of Leeds’ £7 M Centre for Doctoral Training (CDT) in Complex Particulate Products and Processes. The first batch of 10 doctorate students are set to start in Oct 2014. Half of the funding will be covered by the UK government, with the remainder supported by academic and industrial partners such as Procter & Gamble, Syngenta, Infineum, Glaxo-SmithKline, Pfizer and AstraZeneca. Research will focus on microencapsulation, which would enable controlled release and preservation of active ingredients such as pesticides and cleaning products.
Original Source: Chemie Aktuell, 23 Apr 2014, (Website: http://www.maerkte-weltweit.de) (in German) © MBM Martin Brueckner Medien GmbH 2014
COMPANY NEWS CI invests in P2 Science Connecticut Innovations (CI) has made a $500,000 investment in P2 Science Inc of New Haven, CT, USA, through its Eli Whitney Equity Fund. This investment was part of a $1 M Series A funding round also involving Elm Street Ventures. In 2013, CI provided P2 Science with a $500,000 seed investment [Focus on Surfactants, Sep 2013] and earlier provided pre-seed funding. P2 Science, a speciality chemical company dedicated to producing high-value, high-margin consumer
Original Source: Chemical Weekly, 8 Apr 2014, 173 (Website: http://www.chemicalweekly.com) © Sevak Publications & Chemical Weekly Database P Ltd 2014
Dolomite, Sphere Fluidics partner to deliver world-leading droplet-based technology Sphere Fluidics and The Dolomite Centre Ltd have signed an exclusive distributor agreement for Sphere Fluidics’ trademarked range of unique biochips, surfactants and other specialist chemicals for picodroplet applications. These will be promoted and sold via Dolomite’s worldwide sales channels. Original Source: BioSpace, 1 May 2014, (Website: http://www.biospace.com)
7